Zeyi Liu

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Epidermal Growth Factor Receptor

Cell Proliferation

Small Cell Lung Cancer

Top Venues

Scientific reports

Cancer medicine

Journal of experimental & clinical cancer research : CR

Cell death discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Yuanyuan Zeng, Jian Zhao, Zhengyan Wu, Yongkang Huang, Anqi Wang, Jianjie Zhu, Mengmeng Xu, Weijie Zhang, Xiaohui Zhang, Jianjun Li, Jian-An Huang, Zeyi Liu
Targeting TYK2 alleviates Rab27A-induced malignant progression of non-small cell lung cancer via disrupting IFNα-TYK2-STAT-HSPA5 axis. NPJ precision oncology 8 (1) (2024)
Anqi Wang, Jianjie Zhu, Yue Li, Min Jiao, Saiqun Zhang, Zong-Li Ding, Jian-An Huang, Zeyi Liu
Comprehensive analysis of Epha10 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in non-small cell lung cancer. Scientific reports 14 (1) (2024)
Anqi Wang, Jianjie Zhu, Yue Li, Min Jiao, Saiqun Zhang, Zong-Li Ding, Jian-An Huang, Zeyi Liu
Comprehensive analysis of Epha10 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in non-small cell lung cancer. Scientific reports 14 (1) (2024)
Anqi Wang, Jianjie Zhu, Yue Li, Min Jiao, Saiqun Zhang, Zong-Li Ding, Jian-An Huang, Zeyi Liu
Comprehensive analysis of Epha10 as a predictor of clinical prognosis and immune checkpoint therapy efficacy in non-small cell lung cancer. Scientific reports 14 (1) (2024)
Yuanyuan Zeng, Jian Zhao, Zhengyan Wu, Yongkang Huang, Anqi Wang, Jianjie Zhu, Mengmeng Xu, Weijie Zhang, Xiaohui Zhang, Jianjun Li, Jian-An Huang, Zeyi Liu
Targeting TYK2 alleviates Rab27A-induced malignant progression of non-small cell lung cancer via disrupting IFNα-TYK2-STAT-HSPA5 axis. NPJ precision oncology 8 (1) (2024)
Juan Li, Lirong Gao, Anqi Wang, Huiwen Qian, Jianjie Zhu, Shundong Ji, Jun Chen, Zeyi Liu, Cheng Ji
Forkhead box L2 is a target of miR-133b and plays an important role in the pathogenesis of non-small cell lung cancer. Cancer medicine (2023)
Yue Li, Jian Zhao, Weijie Zhang, Anqi Wang, Min Jiao, Xin Cai, Jianjie Zhu, Zeyi Liu, Jian-An Huang
LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway. Cell cycle (Georgetown, Tex.) 21 (23) (2022)
Ruoyi Shen, Xin Cai, Dan Shen, Ruochen Zhang, Weijie Zhang, Yang Zhang, Yue Li, Anqi Wang, Yuanyuan Zeng, Jianjie Zhu, Zeyi Liu, Jian-An Huang
Long noncoding RNA LINC00518 contributes to proliferation and metastasis in lung adenocarcinoma via the miR-335-3p/CTHRC1 Axis. Cell death discovery 8 (1) (2022)
Jieqi Zhou, Anqi Wang, Tingting Cai, Yue Li, Wenwen Du, Yang Zhang, Ruochen Zhang, Weijie Zhang, Jianjie Zhu, Yuanyuan Zeng, Jian-An Huang, Zeyi Liu
Integrin α3/α6 and αV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression. Cell death & disease 13 (5) (2022)
Anqi Wang, Wen Yang, Yue Li, Yang Zhang, Jieqi Zhou, Ruochen Zhang, Weijie Zhang, Jianjie Zhu, Yuanyuan Zeng, Zeyi Liu, Jian-An Huang
CPNE1 promotes non-small cell lung cancer progression by interacting with RACK1 via the MET signaling pathway. Cell communication and signaling : CCS 20 (1) (2022)
Weijie Zhang, Ruochen Zhang, Yuanyuan Zeng, Yue Li, Yikun Chen, Jieqi Zhou, Yang Zhang, Anqi Wang, Jianjie Zhu, Zeyi Liu, Zhaowei Yan, Jian-An Huang
ALCAP2 inhibits lung adenocarcinoma cell proliferation, migration and invasion via the ubiquitination of β-catenin by upregulating the E3 ligase NEDD4L. Cell death & disease 12 (8) (2021)
Jianjie Zhu, Tingting Cai, Jieqi Zhou, Wenwen Du, Yuanyuan Zeng, Ting Liu, Yulong Fu, Yue Li, Qian Qian, Xiuwei H Yang, Qinglin Li, Jian-An Huang, Zeyi Liu
CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Ruochen Zhang, Weijie Zhang, Yuanyuan Zeng, Yue Li, Jieqi Zhou, Yang Zhang, Anqi Wang, Yantian Lv, Jianjie Zhu, Zeyi Liu, Jian-An Huang
The regulation of CPNE1 ubiquitination by the NEDD4L is involved in the pathogenesis of non-small cell lung cancer. Cell death discovery 7 (1) (2021)
Tingting Cai, Jieqi Zhou, Yuanyuan Zeng, Wenwen Du, Yang Zhang, Ting Liu, Yulong Fu, Jian-An Huang, Qian Qian, Jianjie Zhu, Chunhua Ling, Zeyi Liu
EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells. Journal of experimental & clinical cancer research : CR 39 (1) (2020)
Yulong Fu, Yang Zhang, Zhe Lei, Ting Liu, Tingting Cai, Anqi Wang, Wenwen Du, Yuanyuan Zeng, Jianjie Zhu, Zeyi Liu, Jian-An Huang
Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer. Journal of hematology & oncology 13 (1) (2020)
Anqi Wang, Jianjie Zhu, Juan Li, Wenwen Du, Yang Zhang, Tingting Cai, Ting Liu, Yulong Fu, Yuanyuan Zeng, Zeyi Liu, Jian-An Huang
Downregulation of KIAA1199 by miR-486-5p suppresses tumorigenesis in lung cancer. Cancer medicine 9 (15) (2020)
Zengzhi Lian, Wenwen Du, Yang Zhang, Yulong Fu, Ting Liu, Anqi Wang, Tingting Cai, Jianjie Zhu, Yuanyuan Zeng, Zeyi Liu, Jian-An Huang
Anlotinib can overcome acquired resistance to EGFR-TKIs via FGFR1 signaling in non-small cell lung cancer without harboring EGFR T790M mutation. Thoracic cancer 11 (7) (2020)
Chunhua Ling, Xueting Wang, Jianjie Zhu, Haicheng Tang, Wenwen Du, Yuanyuan Zeng, Lin Sun, Jian-An Huang, Zeyi Liu
MicroRNA-4286 promotes cell proliferation, migration, and invasion via PTEN regulation of the PI3K/Akt pathway in non-small cell lung cancer. Cancer medicine 8 (7) (2019)